Tiny Guide RNA Layout for AGO Target Cleavage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The roles and biogenesis pathways of tiny guide RNAs (tyRNAs) in mammals are enigmatic, and existing methods do not effectively optimize the formation of Argonaute (AGO) complexes for target nucleic acid cleavage.
Innovation Solution
Designing guide RNAs that are complementary to a base-pairing region of a target nucleic acid and non-complementary to a non-base-pairing region, allowing AGO molecules to recognize and cleave the target nucleic acid, with methods to identify interaction regions and regulate gene expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If guide RNA is designed to be complementary to the entire target nucleic acid, then binding affinity is improved, but cleavage efficiency is reduced due to AGO molecule inability to recognize non-base-pairing regions
Solution Approach 1:
The guide RNA is segmented into two functional regions: a base-pairing region (nucleotides 2-8) that binds to the target nucleic acid and a non-base-pairing region (nucleotides 9-14) that remains unpaired. This segmentation allows the AGO molecule to recognize the non-base-pairing region for cleavage while maintaining binding affinity through the base-pairing region, resolving the contradiction between binding affinity and cleavage efficiency.
Solution Approach 2:
Different regions of the guide RNA are given different functional qualities: the base-pairing region (nucleotides 2-8) has high complementarity to the target for stable binding, while the non-base-pairing region (nucleotides 9-14) is deliberately designed to be non-complementary to enable AGO recognition and cleavage. This local differentiation of functional properties allows simultaneous optimization of both binding and cleavage.
2Reliability
If guide RNA is designed with high complementarity to the target, then complex formation is improved, but target cleavage is inhibited due to lack of AGO recognition sites
Solution Approach 1:
The guide RNA is divided into a base-pairing region (nucleotides 2-8) that forms stable complexes with the target and a non-base-pairing region (nucleotides 9-14) that serves as an AGO recognition site. This segmentation enables the complex to form reliably through base-pairing while maintaining cleavage capability through the unpaired region that AGO molecules can recognize and act upon.
3Stability of the object's composition
If guide RNA binds to the entire target sequence, then binding stability is improved, but AGO molecule recognition and cleavage activity are reduced
Solution Approach 1:
The guide RNA exhibits local quality differentiation where nucleotides 2-8 provide stable binding through complementarity, while nucleotides 9-14 provide cleavage activity through non-complementarity that enables AGO recognition. This local functional differentiation allows the guide RNA to simultaneously achieve binding stability and cleavage activity without compromise.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the cleavage efficiency of AGO complexes by AGO1, AGO2, and AGO3, enabling targeted gene silencing and potential therapeutic applications for diseases or disorders.
Implementation Method 1
designing a guide RNA which is complementary to a base-pairing region of the target nucleic acid
Implementation Method 2
said AGO molecule, when loaded with said guide RNA, cleaves a target nucleic acid
Data Source
AI summary
Guide RNA can be engineered and used with an Argonaute (AGO) molecule. An AGO molecule can interact within a target nucleic acid, and this interaction can be used in many biotherapeutic and diagnostic methods. For example, gene expression of a target nucleic acid can be regulated using an AGO molecule.